ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory
November 18, 2024
14 Apr 2020

Notice of Annual General Meeting in Acarix AB

Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convene...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Apr 2020

Kallelse till årsstämma i Acarix AB

Kallelse till årsstämma i Acarix AB Aktieägarna i Acarix AB, org.nr 559009-0667, ("Bolaget") kallas härmed till årsstämma to...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Apr 2020

Notice of Annual General Meeting in Acarix AB

Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are here...
Continue reading
author-avatar acarix
Press
August 6, 2024
12 Mar 2020

Acarix får återkoppling från tyska myndigheter gällande ansökan om kostnadsersättning

Pressmeddelande Malmö, Sverige, 12 mars 2020 Acarix får återkoppling från tyska myndigheter gällande ansökan om kostnadsersättning A...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
12 Mar 2020

Acarix får återkoppling från tyska myndigheter gällande ansökan om kostnadsersättning

Pressmeddelande Malmö, Sverige, 12 mars 2020 Acarix får återkoppling från tyska myndigheter gällande ans&...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
12 Mar 2020

Acarix receives feedback on German reimbursement submission

Press releaseMalmö, Sweden March 12, 2020 Acarix receives feedback on German reimbursement submission Acarix AB (publ) today a...
Continue reading
author-avatar acarix
Press
August 6, 2024
12 Mar 2020

Acarix receives feedback on German reimbursement submission

Press releaseMalmö, Sweden March 12, 2020 Acarix receives feedback on German reimbursement submission Acarix AB (publ) today announ...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Regulatory, Report, Swedish, Yearend
November 18, 2024
20 Feb 2020

Framgångsrik nyemission möjliggör ökat fokus på strategiska initiativ

Acarix AB (publ) publicerar Bokslutskommuniké 2019 Malmö den 20 februari 2020 Framgångsrik nyemission möjlig...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Regulatory, Report, Yearend
November 18, 2024
20 Feb 2020

Successful rights issue enables increased focus on strategic initiatives

Acarix AB (publ) publishes Year-End Report 2019 Malmö, January 20, 2020 Successful rights issue enables increased focus on str...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Feb 2020

Framgångsrik nyemission möjliggör ökat fokus på strategiska initiativ

Acarix AB (publ) publicerar Bokslutskommuniké 2019 Malmö den 20 februari 2020 Framgångsrik nyemission möjliggör ökat fokus på strat...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Feb 2020

Successful rights issue enables increased focus on strategic initiatives

Acarix AB (publ) publishes Year-End Report 2019 Malmö, January 20, 2020 Successful rights issue enables increased focus on strategi...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
18 Feb 2020

First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patients

Press release Malmö, Sweden February 18, 2020 First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patie...
Continue reading
  • «
  • ‹
  • 59
  • 60
  • 61
  • 62
  • 63
  • ›
  • »

Acarix AB

Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V6

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.